Vascular Endothelial Growth Factor (VEGF) Concentration Is Underestimated by Enzyme-Linked Immunosorbent Assay in the Presence of Anti-VEGF Drugs | Zendy

Hidenori Takahashi | Zendy; Yoko Nomura | Zendy; Junko Nishida | Zendy; Yujiro Fujino | Zendy; Yasuo Yanagi | Zendy; Hidetoshi Kawashima | Zendy

Open Access

Vascular Endothelial Growth Factor (VEGF) Concentration Is Underestimated by Enzyme-Linked Immunosorbent Assay in the Presence of Anti-VEGF Drugs

Author(s) -

Hidenori Takahashi,

Yoko Nomura,

Junko Nishida,

Yujiro Fujino,

Yasuo Yanagi,

Hidetoshi Kawashima

Publication year - 2016

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.15-18245

Subject(s) - vegf receptors , vascular endothelial growth factor , enzyme , vascular endothelial growth factor a , medicine , vascular endothelial growth factor c , chemistry , endocrinology , biochemistry

Commercially available enzyme-linked immunosorbent assay (ELISA) kits are often used to monitor vascular endothelial growth factor (VEGF) levels in exudative age-related macular degeneration. To test their accuracy, this study performed measurements using the ELISA kits in the presence of anti-VEGF drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research